Concepedia

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial

Ajay Vora, Nick Goulden, Chris Mitchell, Jeremy Hancock, Rachael Hough, Clare Rowntree, Anthony V. Moorman, Rachel Wade

The Lancet Oncology · 2014 · 305 citations · 17 references

DOIFull text

Open access

Concepts

References

17

Practical Statistics for Medical Research.

Sophie Walter, Daniel Altman · Biometrics · 1992 · 11.7K citations

, , +12

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy

Early Breast Cancer Trialist's Collaborative Group · The Lancet · 1992 · 2.2K citations

, , +16

Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation

Ching-Hon Pui, Dario Campana, Deqing Pei et al. · New England Journal of Medicine · 2009 · 1.2K citations · Full text

, , +12

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

Jacques J. M. van Dongen, Taku Seriu, E. Renate Panzer-Grümayer et al. · The Lancet · 1998 · 961 citations

, , +14

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi et al. · Blood · 2010 · 786 citations · Full text

, , +11